| Identification | Back Directory | [Name]
Lorazepam-13C2-d4 (CRM) | [CAS]
2747915-04-2 | [Synonyms]
Lorazepam-13C2-d4 (CRM)
7-chloro-5-(2-chlorophenyl-d4)-3-hydroxy-1,3-dihydro-2H-benzo[e][1,4]diazepin-2-one-2,3-13C2 | [Molecular Formula]
C15H6Cl2D4N2O2 | [MOL File]
2747915-04-2.mol | [Molecular Weight]
327.17 |
| Hazard Information | Back Directory | [Description]
Lorazepam-13C2-d4 (CRM) (Item No. 18731) is a certified reference material intended for use as an internal standard for the quantification of lorazepam (Item Nos. ISO60202 | 15891) by GC- or LC-MS. Lorazepam is categorized as a benzodiazepine that has anxiolytic properties.1,2 It is a metabolite of diclazepam (Item Nos. 28623 | 15554).3 Formulations containing lorazepam have been used in the treatment of anxiety. Lorazepam-13C2-d4 is regulated as a Schedule IV compound in the United States. Lorazepam-13C2-d4 (CRM) (Item No. 18731) is provided as a DEA exempt preparation. This product is intended for research and forensic applications.WARNING This product is not for human or veterinary use. | [Description]
Lorazepam-13C2-d4 (Item No. 17965) is an analytical reference material intended for use as an internal standard for the quantification of lorazepam (Item Nos. ISO60202 | 15891) by GC- or LC-MS. Lorazepam is categorized as a benzodiazepine that has anxiolytic properties.1,2 It is a metabolite of diclazepam (Item Nos. 28623 | 15554).2 Formulations containing lorazepam have been used in the treatment of anxiety. Lorazepam-13C2-d4 is regulated as a Schedule IV compound in the United States. This product is intended for research and forensic applications.WARNING This product is not for human or veterinary use. |
|
|